Skip to main content
. 2011 Feb 17;6(2):e16840. doi: 10.1371/journal.pone.0016840

Table 3. Summary of the primary antibodies used in this study.

Antibody(clone number) Source Optimal dilution Antigen retrieval
Human Vimentin(monoclonal: 280618) R&D (Minneapolis, MN, USA) 1∶50 no retrieval
Human Cytokeratin(monoclonal: KL1) AbD serotec (Oxford, UK) 1∶50 heata, EDTA·Tris (pH9.0)
Human MMP-1(monoclonal: EP1247Y) Epitomics (Burlingame, CA,USA) 1∶100 autoclaveb, citric acid buffer
Human MMP-2(polyclonal) Zhongshan Biotechnology (Beijing, China) 1∶150 autoclaveb, citric acid buffer
Human MMP-9(polyclonal) Zhongshan Biotechnology (Beijing, China) 1∶150 heata, citric acid buffer
Human CD31(monoclonal: JC70A) Dako (Glostrup, Denmark) 1∶40 heata, EDTA (pH8.0)
Mouse CD31(monoclonal: MEC13.3) Biolegend (San Diego, CA, USA) 1∶100 trypsinc
Human CD45(polyclonal) Zhongshan Biotechnology (Beijing, China) 1∶200 heata, citric acid buffer
Mouse CD45(monoclonal:30-F11) BD Pharmingen(San Diego, CA, USA) 1∶150 heata, citric acid buffer
Prolactin(monoclonal: C-17) Santa Cruz (CA, USA) 1∶500 heata, citric acid buffer
a

heat: heat without boiling for 15 min.

b

autoclave: heat in an autoclave for 2 min in citric acid buffer.

c

trypsin: enzymatic digestion by trypsin for 10 min.